Eyes are on a water retention drug called bumetanide after a recent study showed it was correlated with a lower risk of Alzheimer’s in…
An emerging brain technology — transcranial magnetic stimulation — offers a non-invasive way to change the brain for the better, using magnets. Proponents believe…
Nikki Schultek, founder of the global medical research consortium Intracell Research Group, takes a close look at how the COVID-19 pandemic may prompt a…
Two first-of-their-kind studies presented at the Alzheimer’s Association International Conference show transgender and nonbinary adults are more likely show early possible signs of dementia….
In light of last week’s long-awaited FDA decision on experimental Alzheimer’s treatment aducanumab, a panel of clinical trials experts looks at why Alzheimer’s drug…
Geri Taylor, a participant in the aducanumab (Aduhelm) clinical trial, and her husband Jim share insights about taking part in the research. During her…
As part of our BrainTalk series, Being Patient spoke with Dr. Stephen Salloway about the development of aducanumab and what the future holds for…